| MEDI | Sunday, 13 March 2005 | ||
9:00 AM-12:20 PM Convention Center -- Room 6C, Oral | |||
General Oral Session | |||
| Organizer: | Daniel L. Flynn | ||
| Presiding: | Brian S. J. Blagg | ||
| 9:00 AM | 7 | Allosteric enhancers of A1 adenosine receptors Mahendra D. Chordia, Heidi Figler, Ray A. Olsson, Joel Linden | |
| 9:20 AM | 8 | Discovery and efficacy of the first orally administered derivatives of B-type natriuretic peptide Kenneth D. James, Mark A. Miller, Navdeep B. Malkar, Diana Severynse-Stevens, Kevin G. Yarbrough, Karen Polowy, Mark J. Bednarcik, Robert E. Dugdell, Alessandro Cataliotti, John A. Schirger, Radha Krishnan, Monica E. Puskas, David Surguladze, Jenn L. Boyer, Nnochiri N. Ekwuribe, John C. Burnett Jr. | |
| 9:40 AM | 9 | Design and synthesis of orally efficacious Melanin Concentrating Hormone (MCH) receptor antagonists as antiobesity therapeutics Mark D. McBriar, Henry Guzik, Ruo Xu, Jaroslava Paruchova, Shengjian Li, Anandan Palani, Sherry Shapiro, John W. Clader, William J. Greenlee, Brian E. Hawes, Hana Baker, Kim O'Neill, Brian Spar, Blair Weig | |
| 10:00 AM | 10 | Over 100 peptide-activated GPCRs recognize turn motifs in ligands David P. Fairlie, Joel D. A. Tyndall, Giovanni Abbenante, Bernhard Pfeiffer | |
| 10:20 AM | 11 | Novel benzoxazocine analogues as potent analgesic agents Andrew D. Baxter, Michael Lyne, Stuart Brown | |
| 10:40 AM | 12 | Opioid Receptor Like (ORL1/NOP) agonists as novel analgesics Paul D Ratcliffe | |
| 11:00 AM | 13 | A chemical genetics approach for the discovery of novel anti-cancer agents and targets: Identification of transferrin receptor as the molecular target of gambogic acid, a rapid and potent apoptosis-inducer Sui Xiong Cai, Han-Zhong Zhang, Katayoun Jessen, Sergei Maliartchouk, Jean Yu Wang, Nicki English, Ling Qiu, Nilantha Sirisoma, Songchun Jiang, Jared Kuemerle, John Drewe, Kurt Gehlsen, Ben Tseng, Shailaja Kasibhatla | |
| 11:20 AM | 14 | A chemogenomic approach for ion channel and transport modulators Holger Heitsch | |
| 11:40 AM | 15 | Clofibrate-induced changes in the lipid metabolome Craig E. Wheelock, John W. Newman, Steven M. Watkins, Bruce D. Hammock | |
| 12:00 PM | 16 | Rational design of multiple ligands: Risks and benefits J. Richard Morphy | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 229th ACS National Meeting, in San Diego, CA, March 13-17, 2005